CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-13 | Jones Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +33,670 | 33,670 | ||
| 2022-07-13 | Fletcher Kyle General Counsel | Grant or award | +2,297 | 35,432 | ||
| 2022-07-13 | Fletcher Kyle General Counsel | Grant or award · Stock Option (Right to Buy) | +6,735 | 6,735 | ||
| 2022-07-13 | Fletcher Kyle General Counsel | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-07-13 | Smith Robin L Director | Grant or award | +36,145 | 36,145 | ||
| 2022-07-13 | Smith Robin L Director | Grant or award · Stock Option (Right to Buy) | +54,152 | 54,152 | ||
| 2022-07-13 | VON ESCHENBACH ANDREW C. Director | Grant or award | +36,145 | 136,145 | ||
| 2022-07-13 | VON ESCHENBACH ANDREW C. Director | Grant or award · Stock Option (Right to Buy) | +54,152 | 54,152 | ||
| 2022-06-02 | Parks Diane L. Director | Grant or award · Stock Option (Right to Buy) | +42,413 | 42,413 | ||
| 2022-04-13 | Haines John R See Remarks | Grant or award | +65,617 | 65,617 | ||
| 2022-04-13 | Haines John R See Remarks | Grant or award · Stock Option (Right to Buy) | +192,401 | 192,401 | ||
| 2022-04-13 | Hariri Robert J Chief Executive Officer | Grant or award | +131,234 | 7,865,923 | ||
| 2022-04-13 | Hariri Robert J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +384,801 | 384,801 | ||
| 2022-04-13 | Dunn Keary See Remarks | Grant or award | +16,405 | 16,405 | ||
| 2022-04-13 | Dunn Keary See Remarks | Grant or award · Stock Option (Right to Buy) | +48,100 | 48,100 | ||
| 2022-04-13 | Brigido Stephen Pres, Functional Regeneration | Grant or award | +32,809 | 32,809 | ||
| 2022-04-13 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +96,201 | 96,201 | ||
| 2022-04-13 | Beers David C Chief Financial Officer | Grant or award | +41,011 | 41,011 | ||
| 2022-04-13 | Beers David C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +120,251 | 120,251 | ||
| 2022-04-13 | Glover Bradley Chief Technology Officer | Grant or award | +19,686 | 19,686 |
Page 11 of 15 · 299 trades